{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:50:20Z","timestamp":1793962220015,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00004\/09"],"award-info":[{"award-number":["MC_UU_00004\/09"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","award":["300593"],"award-info":[{"award-number":["300593"]}],"id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jclinepi.2025.112002","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:32:58Z","timestamp":1759210378000},"page":"112002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A Bayesian framework to evaluate non-inferiority in randomized controlled trials of uncommon conditions"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-1065","authenticated-orcid":false,"given":"Victoria R.","family":"Cornelius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Elkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-7661","authenticated-orcid":false,"given":"Ian R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-5464","authenticated-orcid":false,"given":"Rebecca M.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3442-3947","authenticated-orcid":false,"given":"Michelle","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Quartango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor D.","family":"Tweed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejal","family":"Saglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-1173","authenticated-orcid":false,"given":"Suzie","family":"Cro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jclinepi.2025.112002_bib3","first-page":"19","article-title":"Noninferiority trials","volume":"1","author":"Snapinn","year":"2000","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.112002_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12916-016-0722-3","article-title":"How do you design randomised trials for smaller populations? A framework","volume":"14","author":"Parmar","year":"2016","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.112002_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13063-017-1859-x","article-title":"Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review","volume":"18","author":"Althunian","year":"2017","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.jclinepi.2025.112002_bib7","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.vaccine.2015.01.072","article-title":"Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials","volume":"33","author":"Donken","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jclinepi.2025.112002_bib8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/eurheartj\/ehs099","article-title":"Non-inferiority study design: lessons to be learned from cardiovascular trials","volume":"33","author":"Head","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2025.112002_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jclinepi.2019.03.003","article-title":"Most noninferiority trials were not designed to preserve active comparator treatment effects","volume":"110","author":"Tsui","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.jclinepi.2025.112002_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012594","article-title":"Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals","volume":"6","author":"Rehal","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jclinepi.2025.112002_bib11","series-title":"Bayesian adaptive methods for clinical trials","author":"Berry","year":"2010"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.112002_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2307\/2983527","article-title":"Bayesian approaches to randomized trials","volume":"157","author":"Spiegelhalter","year":"1994","journal-title":"J R Stat Soc Ser A"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.112002_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","article-title":"Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations","volume":"31","author":"Greenland","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"9265","key":"10.1016\/j.jclinepi.2025.112002_bib14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(00)04522-0","article-title":"Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours","volume":"357","author":"Shakespeare","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.112002_bib15","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDctw2200018","article-title":"Improving clinical trial interpretation with ACCEPT analyses","volume":"1","author":"Clements","year":"2022","journal-title":"NEJM Evid"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.112002_bib16","first-page":"417","article-title":"Why are not there more bayesian clinical trials? Perceived barriers and educational preferences among medical researchers involved in drug development","volume":"57","author":"Clark","year":"2022","journal-title":"Ther Innov Regul Sci"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.112002_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.berh.2014.03.004","article-title":"Methodology of clinical trials for rare diseases","volume":"28","author":"Tudur Smith","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.112002_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejca.2014.10.027","article-title":"Clinical trial designs for rare diseases: studies developed and discussed by the international rare cancers initiative","volume":"51","author":"Bogaerts","year":"2015","journal-title":"Eur J Cancer"},{"issue":"7020","key":"10.1016\/j.jclinepi.2025.112002_bib21","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/bmj.311.7020.1621","article-title":"Clinical trials and rare diseases: a way out of a conundrum","volume":"311","author":"Lilford","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.112002_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1927","article-title":"Bayesian clinical trials","volume":"5","author":"Berry","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.112002_bib23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/ijerph18031022","article-title":"Bayesian approaches for confirmatory trials in rare diseases: opportunities and challenges","volume":"18","author":"Ursino","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jclinepi.2025.112002_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","article-title":"Approximate bayesian inference for latent gaussian models by using integrated nested laplace approximations","volume":"71","author":"Rue","year":"2009","journal-title":"J R Stat Soc Ser B-Statistical Methodol"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.112002_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-090749","article-title":"Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial","volume":"14","author":"Cornelius","year":"2024","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.112002_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa1001278","article-title":"Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids","volume":"362","author":"Lemanske","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.112002_bib27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/sim.9661","article-title":"Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes","volume":"42","author":"Turner","year":"2022","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2025.112002_bib28","series-title":"Uncertain Judgements: Eliciting Experts\u2019 Probabilities","author":"O\u2019Hagan","year":"2006"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.112002_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/pst.1848","article-title":"Approaches to sample size calculation for clinical trials in rare diseases","volume":"17","author":"Miller","year":"2018","journal-title":"Pharm Stat"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.112002_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12874-019-0826-5","article-title":"A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events","volume":"19","author":"Aupiais","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jclinepi.2025.112002_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jclinepi.2021.12.009","article-title":"Design and analysis features used in small population and rare disease trials: a targeted review","volume":"144","author":"Partington","year":"2022","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543562500335X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543562500335X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:20:42Z","timestamp":1793060442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089543562500335X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S089543562500335X"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.112002","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Bayesian framework to evaluate non-inferiority in randomized controlled trials of uncommon conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.112002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112002"}}